Affymax Research Institute

From kogic.kr
Revision as of 13:59, 15 January 2008 by WikiSysop (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Specializing in field of combinatorial chemistry with a portfolio of technologies that enable synthesis, screening and optimization of potential new drug compounds. 

Subsidiary of GlaxoSmithKline. 

Biocompany.net

Retrieved from "http://kogic.kr/index.php?title=Affymax_Research_Institute&oldid=1894"